-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley (MS) Stock Could Be 19% Overvalued Despite Wealth Shift News

Simply Wall St·07/14/2026 18:42:19
Listen to the news

Morgan Stanley’s stock has almost tripled over the past five years, yet its current checks point to a company that screens as expensive on an intrinsic value basis while trading at roughly in line earnings multiples, raising the question of how much upside is already reflected in the US$221.09 share price.

  • A roughly 191% return over five years puts Morgan Stanley among the stronger performers in large financials, which can leave less room for error if expectations reset.
  • The shift toward adviser led wealth management as a key earnings engine may support expectations for durable fee based income, while questions around broader market risks, including AI related capital spending and equity market sensitivity, can weigh on how much investors are willing to pay.
  • With only 2 of 6 valuation checks suggesting value, Morgan Stanley does not screen as a clear bargain on the broader tests and the Excess Returns model currently indicates the stock trades at a premium to its intrinsic value estimate.

The issue now is whether Morgan Stanley’s recent strength and premium to its intrinsic value estimate leave enough compensation for the risks that come with owning the stock at today’s price.

Morgan Stanley delivered 57.3% returns over the last year. See how this stacks up to the rest of the Capital Markets industry.

Has Morgan Stanley Run Too Far on Excess Returns?

The Excess Returns model looks at how effectively Morgan Stanley turns its equity base into earnings above its estimated cost of capital. For Morgan Stanley, the model uses a Book Value of $66.18 per share and a Stable EPS of $13.23 per share, implying an average Return on Equity of 18.04% versus a Cost of Equity of $6.78 per share and an estimated Excess Return of $6.45 per share. That profile, along with a Stable Book Value of $73.36 per share, supports an intrinsic value estimate of $186.43 per share.

With the stock at about $221.09, Morgan Stanley screens as roughly 18.6% overvalued on this Excess Returns view. The recent shift of over $1 trillion into adviser-led wealth management may help explain why the market is comfortable paying above the model’s intrinsic value estimate.

On these Excess Returns assumptions, Morgan Stanley stock currently looks overvalued relative to its intrinsic value estimate.

Our Excess Returns analysis suggests Morgan Stanley may be overvalued by 18.6%. Discover 46 high quality undervalued stocks or create your own screener to find better value opportunities.

MS Discounted Cash Flow as at Jul 2026
MS Discounted Cash Flow as at Jul 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Morgan Stanley.

Is Morgan Stanley Fairly Priced on Earnings?

P/E is a useful yardstick for Morgan Stanley because earnings remain a central anchor for how investors value large capital markets and wealth management groups. On this measure, Morgan Stanley trades on about 19.9x earnings, below both the Capital Markets industry average P/E of 40.1x and the peer average of 32.7x, so the stock does not look stretched against broad sector benchmarks.

The fair P/E ratio implied by the model reflects Morgan Stanley’s specific mix of growth expectations, margins, size and risk, and sits at around 19.3x. That is very close to the current 19.9x multiple, suggesting the market price is roughly in line with what these fundamentals would point to, even after the strong wealth management driven story and recent earnings strength highlighted in market commentary.

On the P/E multiple, Morgan Stanley stock currently looks priced roughly in line with what the company’s fundamentals would justify.

NYSE:MS P/E Ratio as at Jul 2026
NYSE:MS P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Morgan Stanley Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Morgan Stanley pick up where the valuation checks leave off by spelling out which paths for Morgan Stanley's growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price. Instead of stopping at a single ratio or model output, they clarify the future that number relies on, so you can follow whether that story is playing out on the Community page.

Community views on Morgan Stanley sit on a tightrope, with one camp seeing long term upside in its wealth and AI push while others focus on concentration and competition risks.

Bull case: roughly fairly valued

"The firm's advanced deployment of AI, data analytics, and end-to-end digital tools across self-directed, adviser-led, and workplace channels is poised to significantly reduce operating costs and boost advisor productivity..."

Read the full Bull Case to see why Morgan Stanley could be undervalued

Bear case: roughly fairly valued

"The accelerating shift toward passive investing and ETFs over active management threatens Morgan Stanley's growth in fee-based asset management, potentially leading to long-term revenue and net margin compression..."

Read the full Bear Case to see why Morgan Stanley could be overvalued

Do you think there's more to the story for Morgan Stanley? Head over to our Community to see what others are saying!

The Bottom Line

For Morgan Stanley, the Excess Returns intrinsic value estimate sits below the current share price, while the tailored P/E work suggests the stock is trading at roughly the level its earnings profile supports. That split reflects one framework that is more cautious on the value of future excess returns and another that leans on how the market currently prices similar earnings streams. With broader valuation checks scoring on the weaker side, the stock no longer screens as an obvious bargain. The key question from here is whether Morgan Stanley can sustain its adviser led wealth momentum without investors marking down the multiple it trades on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.